Anti-CD152重组抗体|科研级 Tremelimumab ( 曲美木单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-CD152重组抗体|科研级 Tremelimumab ( 曲美木单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-CD152重组抗体|科研级 Tremelimumab ( 曲美木单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1160

Alias

科研级 Tremelimumab ( 曲美木单抗 ), Anti-CD152 Recombinant Antibody, Research Grade Tremelimumab

Molecular Name

Tremelimumab

Size

1mg, 5mg

CAS Number

745013-59-6

Isotype

IgG2 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Applications

IF, IP, Neut, FuncS, ELISA

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

CTLA4/CD152[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Tremelimumab (formerly ticilimumab, CP-675, 206) is a fully human monoclonal antibody against CTLA-4. It is an immune checkpoint blocker. Previously in development by Pfizer, it is now in investigation by MedImmune, a wholly owned subsidiary of AstraZeneca. It has been undergoing human trials for the treatment of various cancers but has not attained approval for any.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ